IGF2BP3 (IMP3) expression is a marker of unfavourable prognosis in colorectal cancer

BACKGROUND: Evidence suggests that insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3, also known as IMP3) represents a promising cancer biomarker. However, the clinical, pathological, molecular, and prognostic features of IGF2BP3-positive colorectal cancers remain uncertain. MATE...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lochhead, Paul, Imamura, Yu, Morikawa, Teppei, Kuchiba, Aya, Yamauchi, Mai, Liao, Xiaoyun, Qian, Zhi Rong, Nishihara, Reiko, Wu, Kana, Meyerhardt, Jeffrey A., Fuchs, Charles S., Ogino, Shuji
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3613860/
https://ncbi.nlm.nih.gov/pubmed/22840368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2012.06.021
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares